Navigation Links
VAP(R) Cholesterol Test Highlighted in Groundbreaking Book on Longevity
Date:7/7/2009

BIRMINGHAM, Ala., July 7 /PRNewswire/ -- The VAP(R) Cholesterol Test recently gained the honor of being a component in one of nine steps to a longer life. TRANSCEND: Nine Steps to Living Well Forever (Rodale, 2009) by anti-aging authority Terry Grossman, M.D., and world-renowned futurist Ray Kurzweil, identifies the VAP advanced lipid profile as one of the future technologies in cardiovascular risk assessment.

Grossman, the book's co-author and medical director of The Grossman Wellness Center (www.grossmanwellness.com) in Golden, Colo., describes how America's greatest health threat is lack of early detection and lack of testing. Grossman, who uses the VAP Test at his Denver-area practice, said he believes that virtually all disease is discoverable and, with an aggressive approach, treatable.

The VAP (Vertical Auto Profile) Test is manufactured by Atherotech, Inc., a cardio-diagnostic company based in Birmingham, Ala. Company President Mike Mullen said inclusion of the VAP Test in the book furthers the validity of the test and its ability to identify cardiovascular risks far better than the standard cholesterol test.

"By highlighting the VAP Test in this powerful book on health and longevity, the authors recognize the unique cardiovascular assessment that our test provides to proactive, preventive-minded physicians and their patients," Mullen said.

TRANSCEND is described as a practical, easy-to-understand application of the breakthrough scientific findings on life extension. Under the heading of "How To Keep Your Heart Beating" in the chapter entitled "Blood Tests For Early Detection Of Cardiovascular Disease," the authors state:

         "When a standard panel is run, the total cholesterol, HDL and
         triglycerides are measured, while the LDL is calculated from the
         other results. In the VAP test, LDL is measured directly, providing
         much more accurate information than a calculated value.

         VAP also measures lipoprotein(a), IDL, and VDL, risk factors found to
         be more important than total cholesterol and LDL. Finally, VAP
         fractionates or splits HDL, the beneficial form of cholesterol, into
         HDL-2 and HDL-3 subunits. HDL-2 is much more protective than HDL-3.
         Low HDL-2 is a significant risk factor for cardiovascular disease."

The TRANSCEND authors urge people to take advantage of the accelerating developments in biotechnology and offer everything from updates on relevant research to tips on talking to your doctor about cutting-edge testing.

The VAP Test reports 20 separate components of blood cholesterol as opposed to four in a standard cholesterol test. The test can identify a far greater number of lipid abnormalities -- the No. 1 risk factor for heart disease -- than the standard cholesterol test and now reports apoAI and the apoB/apoAI ratio at no added cost.

People with a family history or an existing condition of diabetes, high blood pressure or heart disease -- or who are already taking cholesterol-lowering medication -- are candidates for the comprehensive VAP Test. In addition, those who don't score within the desirable ranges of the standard cholesterol test (i.e. those with triglycerides > 150, HDL < 40, LDL >130, total cholesterol > 200) should also opt for the more detailed VAP Test.

The VAP Test is available nationwide and covered by most insurance providers, including Medicare and Medicaid. For more information call 877.901.8510 or visit www.thevaptest.com.

About Atherotech, Inc.

Atherotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. It is the only advanced lipid profile that routinely reports all three lipoprotein parameters considered necessary by the American Diabetes Association and American College of Cardiology expert consensus guidelines. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.thevaptest.com.


'/>"/>
SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genes Linked to Cholesterol in Cells Are Identified
2. Kardea Enhances Medical Nutrition System for Cholesterol Lowering
3. Vitamin D Linked to HDL Cholesterol - Shaklee Corporation Research Links Vitamin D with Key Biomarkers for Metabolic Syndrome and Heart Disease
4. Cholesterol Drugs May Help in Cardiac Emergency
5. Managing Blood Pressure, Cholesterol Cuts Stroke Risk
6. Controlling Cholesterol, Blood Pressure Adds Up to Prevent Stroke
7. PDAs, more education help doctors follow cholesterol treatment guidelines
8. New Study Shows Fish Oil Improves Cholesterol Levels in Professional Football Players
9. Cheerios(R) Can Help Reduce Cholesterol 10 Percent in One Month
10. Acetaminophen, Cholesterol Drugs May Help Fight Stroke
11. CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... company is unveiling its revolutionary new 2.0 version at the International Roofing Expo ... “put the power of the world's most advanced weather technology in the hands ...
(Date:2/10/2016)... Garland, TX (PRWEB) , ... February 10, 2016 ... ... the commencement of a master charity program created to assist the local community. ... closely with community leaders and nonprofit organizations in the area. Their goal is ...
(Date:2/10/2016)... ... , ... Ongoing news of the ravages of traumatic brain injury (TBI) among ... that takes a closer look at cases of TBI being managed by their members. ... among the aging population, and identifies the challenges associated with their care. , During ...
(Date:2/10/2016)... ... 2016 , ... Armune BioScience signed a definitive agreement with ... centers across the country. Launched in April of 2015, Apifiny is the only cancer ... Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... been awarded the prestigious Distinguished Emerald Club of the World award, as determined ... magazine, one of the most respected trade publications serving private clubs. , “We’d ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Jersey and OR AKIVA, Israel ... Regentis Biomaterials Ltd., a leader in the ... Series D investment round on February 5, 2016. The ... Group ("Haisco"), a leading Chinese pharmaceutical manufacturer, and ... SCP Vitalife Partners, Generali Financial Holdings and both the ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... 2016 On Tuesday, February 9th, the ... with its Arthritis Advisory Committee to discuss ... & Johnson,s Remicade and most likely the ... U.S. The Biologics Prescribers Collaborative (BPC) along ... for Patient Access, American Association of Clinical ...
Breaking Medicine Technology: